UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:ADCY9-GLYR1 |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: ADCY9-GLYR1 | FusionPDB ID: 2258 | FusionGDB2.0 ID: 2258 | Hgene | Tgene | Gene symbol | ADCY9 | GLYR1 | Gene ID | 115 | 84656 |
Gene name | adenylate cyclase 9 | glyoxylate reductase 1 homolog | |
Synonyms | AC9|ACIX | BM045|HIBDL|N-PAC|NP60|hNDF | |
Cytomap | 16p13.3 | 16p13.3 | |
Type of gene | protein-coding | protein-coding | |
Description | adenylate cyclase type 9ATP pyrophosphate-lyase 9adenylate cyclase type IXadenylyl cyclase 9type IX ATP pyrophosphate-lyase | putative oxidoreductase GLYR13-hydroxyisobutyrate dehydrogenase-like proteincytokine-like nuclear factor n-pacnuclear protein 60 kDanuclear protein 60kDanuclear protein NP60nuclear protein of 60 kDanucleosome-destabilizing factor | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | O60503 | Q49A26 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000294016, ENST00000571889, | ENST00000586901, ENST00000321919, ENST00000381983, ENST00000436648, ENST00000591451, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 27 X 12 X 11=3564 | 9 X 6 X 7=378 |
# samples | 27 | 10 | |
** MAII score | log2(27/3564*10)=-3.72246602447109 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(10/378*10)=-1.91838623444635 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: ADCY9 [Title/Abstract] AND GLYR1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | ADCY9(4038995)-GLYR1(4862249), # samples:3 GLYR1(4895075)-ADCY9(4057559), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | ADCY9-GLYR1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ADCY9-GLYR1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ADCY9-GLYR1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ADCY9-GLYR1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. GLYR1-ADCY9 seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF. GLYR1-ADCY9 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. GLYR1-ADCY9 seems lost the major protein functional domain in Hgene partner, which is a transcription factor due to the frame-shifted ORF. GLYR1-ADCY9 seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. GLYR1-ADCY9 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. GLYR1-ADCY9 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ADCY9 | GO:0006171 | cAMP biosynthetic process | 9628827|10987815 |
Hgene | ADCY9 | GO:0007189 | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 9628827 |
Tgene | GLYR1 | GO:0035066 | positive regulation of histone acetylation | 29759984 |
Tgene | GLYR1 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 29759984 |
Fusion gene breakpoints across ADCY9 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across GLYR1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-E9-A1RH-01A | ADCY9 | chr16 | 4038995 | - | GLYR1 | chr16 | 4862249 | - |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000294016 | ADCY9 | chr16 | 4038995 | - | ENST00000436648 | GLYR1 | chr16 | 4862249 | - | 5425 | 2849 | 539 | 3391 | 950 |
ENST00000294016 | ADCY9 | chr16 | 4038995 | - | ENST00000321919 | GLYR1 | chr16 | 4862249 | - | 5425 | 2849 | 539 | 3391 | 950 |
ENST00000294016 | ADCY9 | chr16 | 4038995 | - | ENST00000381983 | GLYR1 | chr16 | 4862249 | - | 5422 | 2849 | 539 | 3391 | 950 |
ENST00000294016 | ADCY9 | chr16 | 4038995 | - | ENST00000591451 | GLYR1 | chr16 | 4862249 | - | 3579 | 2849 | 539 | 3391 | 950 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000294016 | ENST00000436648 | ADCY9 | chr16 | 4038995 | - | GLYR1 | chr16 | 4862249 | - | 0.001230397 | 0.9987696 |
ENST00000294016 | ENST00000321919 | ADCY9 | chr16 | 4038995 | - | GLYR1 | chr16 | 4862249 | - | 0.001230397 | 0.9987696 |
ENST00000294016 | ENST00000381983 | ADCY9 | chr16 | 4038995 | - | GLYR1 | chr16 | 4862249 | - | 0.001240604 | 0.9987594 |
ENST00000294016 | ENST00000591451 | ADCY9 | chr16 | 4038995 | - | GLYR1 | chr16 | 4862249 | - | 0.003473002 | 0.996527 |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >2258_2258_1_ADCY9-GLYR1_ADCY9_chr16_4038995_ENST00000294016_GLYR1_chr16_4862249_ENST00000321919_length(amino acids)=950AA_BP=770 MASPPHQQLLHHHSTEVSCDSSGDSNSVRVKINPKQLSSNSHPKHCKYSISSSCSSSGDSGGVPRRVGGGGRLRRQKKLPQLFERASSRW WDPKFDSVNLEEACLERCFPQTQRRFRYALFYIGFACLLWSIYFAVHMRSRLIVMVAPALCFLLVCVGFFLFTFTKLYARHYAWTSLALT LLVFALTLAAQFQVLTPVSGRGDSSNLTATARPTDTCLSQVGSFSMCIEVLFLLYTVMHLPLYLSLCLGVAYSVLFETFGYHFRDEACFP SPGAGALHWELLSRGLLHGCIHAIGVHLFVMSQVRSRSTFLKVGQSIMHGKDLEVEKALKERMIHSVMPRIIADDLMKQGDEESENSVKR HATSSPKNRKKKSSIQKAPIAFRPFKMQQIEEVSILFADIVGFTKMSANKSAHALVGLLNDLFGRFDRLCEETKCEKISTLGDCYYCVAG CPEPRADHAYCCIEMGLGMIKAIEQFCQEKKEMVNMRVGVHTGTVLCGILGMRRFKFDVWSNDVNLANLMEQLGVAGKVHISEATAKYLD DRYEMEDGKVIERLGQSVVADQLKGLKTYLISGQRAKESRCSCAEALLSGFEVIDGSQVSSGPRGQGTASSGNVSDLAQTVKTFDNLKTC PSCGITFAPKSEAGAEGGAPQNGCQDEHKNSTKASGGPNPKTQNGLLSPPQEEKLTNSQTSLCEILQEKGRWAGVSLDQSALLPLRFKNI REKTDAHFVDVIKEDSLMKDYFFKPPINQFSLNFLDQELERSYRTSYQEEVIVSRGGRFLEAPVSGNQQLSNDGMLVILAAGDRGLYEDC SSCFQAMGKTSFFLGEVGNAAKMMLIVNMVQGSFMATIAEGLTLAHVTGQSQQTLLDILNQGQLASIFLDQKCQNILQGNFKPDFYLKYI -------------------------------------------------------------- >2258_2258_2_ADCY9-GLYR1_ADCY9_chr16_4038995_ENST00000294016_GLYR1_chr16_4862249_ENST00000381983_length(amino acids)=950AA_BP=770 MASPPHQQLLHHHSTEVSCDSSGDSNSVRVKINPKQLSSNSHPKHCKYSISSSCSSSGDSGGVPRRVGGGGRLRRQKKLPQLFERASSRW WDPKFDSVNLEEACLERCFPQTQRRFRYALFYIGFACLLWSIYFAVHMRSRLIVMVAPALCFLLVCVGFFLFTFTKLYARHYAWTSLALT LLVFALTLAAQFQVLTPVSGRGDSSNLTATARPTDTCLSQVGSFSMCIEVLFLLYTVMHLPLYLSLCLGVAYSVLFETFGYHFRDEACFP SPGAGALHWELLSRGLLHGCIHAIGVHLFVMSQVRSRSTFLKVGQSIMHGKDLEVEKALKERMIHSVMPRIIADDLMKQGDEESENSVKR HATSSPKNRKKKSSIQKAPIAFRPFKMQQIEEVSILFADIVGFTKMSANKSAHALVGLLNDLFGRFDRLCEETKCEKISTLGDCYYCVAG CPEPRADHAYCCIEMGLGMIKAIEQFCQEKKEMVNMRVGVHTGTVLCGILGMRRFKFDVWSNDVNLANLMEQLGVAGKVHISEATAKYLD DRYEMEDGKVIERLGQSVVADQLKGLKTYLISGQRAKESRCSCAEALLSGFEVIDGSQVSSGPRGQGTASSGNVSDLAQTVKTFDNLKTC PSCGITFAPKSEAGAEGGAPQNGCQDEHKNSTKASGGPNPKTQNGLLSPPQEEKLTNSQTSLCEILQEKGRWAGVSLDQSALLPLRFKNI REKTDAHFVDVIKEDSLMKDYFFKPPINQFSLNFLDQELERSYRTSYQEEVIVSRGGRFLEAPVSGNQQLSNDGMLVILAAGDRGLYEDC SSCFQAMGKTSFFLGEVGNAAKMMLIVNMVQGSFMATIAEGLTLAHVTGQSQQTLLDILNQGQLASIFLDQKCQNILQGNFKPDFYLKYI -------------------------------------------------------------- >2258_2258_3_ADCY9-GLYR1_ADCY9_chr16_4038995_ENST00000294016_GLYR1_chr16_4862249_ENST00000436648_length(amino acids)=950AA_BP=770 MASPPHQQLLHHHSTEVSCDSSGDSNSVRVKINPKQLSSNSHPKHCKYSISSSCSSSGDSGGVPRRVGGGGRLRRQKKLPQLFERASSRW WDPKFDSVNLEEACLERCFPQTQRRFRYALFYIGFACLLWSIYFAVHMRSRLIVMVAPALCFLLVCVGFFLFTFTKLYARHYAWTSLALT LLVFALTLAAQFQVLTPVSGRGDSSNLTATARPTDTCLSQVGSFSMCIEVLFLLYTVMHLPLYLSLCLGVAYSVLFETFGYHFRDEACFP SPGAGALHWELLSRGLLHGCIHAIGVHLFVMSQVRSRSTFLKVGQSIMHGKDLEVEKALKERMIHSVMPRIIADDLMKQGDEESENSVKR HATSSPKNRKKKSSIQKAPIAFRPFKMQQIEEVSILFADIVGFTKMSANKSAHALVGLLNDLFGRFDRLCEETKCEKISTLGDCYYCVAG CPEPRADHAYCCIEMGLGMIKAIEQFCQEKKEMVNMRVGVHTGTVLCGILGMRRFKFDVWSNDVNLANLMEQLGVAGKVHISEATAKYLD DRYEMEDGKVIERLGQSVVADQLKGLKTYLISGQRAKESRCSCAEALLSGFEVIDGSQVSSGPRGQGTASSGNVSDLAQTVKTFDNLKTC PSCGITFAPKSEAGAEGGAPQNGCQDEHKNSTKASGGPNPKTQNGLLSPPQEEKLTNSQTSLCEILQEKGRWAGVSLDQSALLPLRFKNI REKTDAHFVDVIKEDSLMKDYFFKPPINQFSLNFLDQELERSYRTSYQEEVIVSRGGRFLEAPVSGNQQLSNDGMLVILAAGDRGLYEDC SSCFQAMGKTSFFLGEVGNAAKMMLIVNMVQGSFMATIAEGLTLAHVTGQSQQTLLDILNQGQLASIFLDQKCQNILQGNFKPDFYLKYI -------------------------------------------------------------- >2258_2258_4_ADCY9-GLYR1_ADCY9_chr16_4038995_ENST00000294016_GLYR1_chr16_4862249_ENST00000591451_length(amino acids)=950AA_BP=770 MASPPHQQLLHHHSTEVSCDSSGDSNSVRVKINPKQLSSNSHPKHCKYSISSSCSSSGDSGGVPRRVGGGGRLRRQKKLPQLFERASSRW WDPKFDSVNLEEACLERCFPQTQRRFRYALFYIGFACLLWSIYFAVHMRSRLIVMVAPALCFLLVCVGFFLFTFTKLYARHYAWTSLALT LLVFALTLAAQFQVLTPVSGRGDSSNLTATARPTDTCLSQVGSFSMCIEVLFLLYTVMHLPLYLSLCLGVAYSVLFETFGYHFRDEACFP SPGAGALHWELLSRGLLHGCIHAIGVHLFVMSQVRSRSTFLKVGQSIMHGKDLEVEKALKERMIHSVMPRIIADDLMKQGDEESENSVKR HATSSPKNRKKKSSIQKAPIAFRPFKMQQIEEVSILFADIVGFTKMSANKSAHALVGLLNDLFGRFDRLCEETKCEKISTLGDCYYCVAG CPEPRADHAYCCIEMGLGMIKAIEQFCQEKKEMVNMRVGVHTGTVLCGILGMRRFKFDVWSNDVNLANLMEQLGVAGKVHISEATAKYLD DRYEMEDGKVIERLGQSVVADQLKGLKTYLISGQRAKESRCSCAEALLSGFEVIDGSQVSSGPRGQGTASSGNVSDLAQTVKTFDNLKTC PSCGITFAPKSEAGAEGGAPQNGCQDEHKNSTKASGGPNPKTQNGLLSPPQEEKLTNSQTSLCEILQEKGRWAGVSLDQSALLPLRFKNI REKTDAHFVDVIKEDSLMKDYFFKPPINQFSLNFLDQELERSYRTSYQEEVIVSRGGRFLEAPVSGNQQLSNDGMLVILAAGDRGLYEDC SSCFQAMGKTSFFLGEVGNAAKMMLIVNMVQGSFMATIAEGLTLAHVTGQSQQTLLDILNQGQLASIFLDQKCQNILQGNFKPDFYLKYI -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr16:4038995/chr16:4862249) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
ADCY9 | GLYR1 |
FUNCTION: Adenylyl cyclase that catalyzes the formation of the signaling molecule cAMP in response to activation of G protein-coupled receptors (PubMed:9628827, PubMed:12972952, PubMed:15879435, PubMed:10987815). Contributes to signaling cascades activated by CRH (corticotropin-releasing factor), corticosteroids and beta-adrenergic receptors (PubMed:9628827). {ECO:0000269|PubMed:10987815, ECO:0000269|PubMed:12972952, ECO:0000269|PubMed:15879435, ECO:0000269|PubMed:9628827}. | FUNCTION: Nucleosome-destabilizing factor that is recruited to genes during transcriptional activation (PubMed:29759984). Facilitates Pol II transcription through nucleosomes (PubMed:29759984). Binds DNA (in vitro) (PubMed:29759984). Recognizes and binds trimethylated 'Lys-36' of histone H3 (H3K36me3) (PubMed:20850016). Promotes KDM1B demethylase activity (PubMed:23260659). Stimulates the acetylation of 'Lys-56' of nucleosomal histone H3 (H3K56ac) by EP300 (PubMed:29759984). Regulates p38 MAP kinase activity by mediating stress activation of p38alpha/MAPK14 and specifically regulating MAPK14 signaling (PubMed:16352664). Indirectly promotes phosphorylation of MAPK14 and activation of ATF2 (PubMed:16352664). The phosphorylation of MAPK14 requires upstream activity of MAP2K4 and MAP2K6 (PubMed:16352664). Putative oxidoreductase (PubMed:23260659). {ECO:0000269|PubMed:16352664, ECO:0000269|PubMed:20850016, ECO:0000269|PubMed:23260659, ECO:0000269|PubMed:29759984}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 394_521 | 770.0 | 1354.0 | Domain | Guanylate cyclase 1 |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 399_404 | 770.0 | 1354.0 | Nucleotide binding | ATP |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 441_443 | 770.0 | 1354.0 | Nucleotide binding | ATP |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 139_141 | 770.0 | 1354.0 | Topological domain | Extracellular |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 163_171 | 770.0 | 1354.0 | Topological domain | Cytoplasmic |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 193_215 | 770.0 | 1354.0 | Topological domain | Extracellular |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 1_117 | 770.0 | 1354.0 | Topological domain | Cytoplasmic |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 236_241 | 770.0 | 1354.0 | Topological domain | Cytoplasmic |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 260_280 | 770.0 | 1354.0 | Topological domain | Extracellular |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 118_138 | 770.0 | 1354.0 | Transmembrane | Helical |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 142_162 | 770.0 | 1354.0 | Transmembrane | Helical |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 172_192 | 770.0 | 1354.0 | Transmembrane | Helical |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 216_235 | 770.0 | 1354.0 | Transmembrane | Helical |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 242_259 | 770.0 | 1354.0 | Transmembrane | Helical |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 281_301 | 770.0 | 1354.0 | Transmembrane | Helical |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 1058_1198 | 770.0 | 1354.0 | Domain | Guanylate cyclase 2 |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 1185_1187 | 770.0 | 1354.0 | Nucleotide binding | ATP |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 1192_1196 | 770.0 | 1354.0 | Nucleotide binding | ATP |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 302_786 | 770.0 | 1354.0 | Topological domain | Cytoplasmic |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 808_818 | 770.0 | 1354.0 | Topological domain | Extracellular |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 840_867 | 770.0 | 1354.0 | Topological domain | Cytoplasmic |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 889_891 | 770.0 | 1354.0 | Topological domain | Extracellular |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 913_920 | 770.0 | 1354.0 | Topological domain | Cytoplasmic |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 942_975 | 770.0 | 1354.0 | Topological domain | Extracellular |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 997_1353 | 770.0 | 1354.0 | Topological domain | Cytoplasmic |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 787_807 | 770.0 | 1354.0 | Transmembrane | Helical |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 819_839 | 770.0 | 1354.0 | Transmembrane | Helical |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 868_888 | 770.0 | 1354.0 | Transmembrane | Helical |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 892_912 | 770.0 | 1354.0 | Transmembrane | Helical |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 921_941 | 770.0 | 1354.0 | Transmembrane | Helical |
Hgene | ADCY9 | chr16:4038995 | chr16:4862249 | ENST00000294016 | - | 6 | 11 | 976_996 | 770.0 | 1354.0 | Transmembrane | Helical |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000321919 | 11 | 16 | 168_180 | 373.0 | 554.0 | DNA binding | A.T hook | |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000381983 | 10 | 15 | 168_180 | 356.0 | 537.0 | DNA binding | A.T hook | |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000436648 | 10 | 15 | 168_180 | 292.0 | 473.0 | DNA binding | A.T hook | |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000591451 | 11 | 16 | 168_180 | 367.0 | 548.0 | DNA binding | A.T hook | |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000321919 | 11 | 16 | 8_66 | 373.0 | 554.0 | Domain | PWWP | |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000381983 | 10 | 15 | 8_66 | 356.0 | 537.0 | Domain | PWWP | |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000436648 | 10 | 15 | 8_66 | 292.0 | 473.0 | Domain | PWWP | |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000591451 | 11 | 16 | 8_66 | 367.0 | 548.0 | Domain | PWWP | |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000321919 | 11 | 16 | 271_285 | 373.0 | 554.0 | Nucleotide binding | NAD | |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000381983 | 10 | 15 | 271_285 | 356.0 | 537.0 | Nucleotide binding | NAD | |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000436648 | 10 | 15 | 271_285 | 292.0 | 473.0 | Nucleotide binding | NAD | |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000591451 | 11 | 16 | 271_285 | 367.0 | 548.0 | Nucleotide binding | NAD |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
ADCY9 | |
GLYR1 |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000321919 | 11 | 16 | 214_217 | 373.0 | 554.0 | histone H3 | |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000381983 | 10 | 15 | 214_217 | 356.0 | 537.0 | histone H3 | |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000436648 | 10 | 15 | 214_217 | 292.0 | 473.0 | histone H3 | |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000591451 | 11 | 16 | 214_217 | 367.0 | 548.0 | histone H3 | |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000321919 | 11 | 16 | 216_225 | 373.0 | 554.0 | KDM1B | |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000381983 | 10 | 15 | 216_225 | 356.0 | 537.0 | KDM1B | |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000436648 | 10 | 15 | 216_225 | 292.0 | 473.0 | KDM1B | |
Tgene | GLYR1 | chr16:4038995 | chr16:4862249 | ENST00000591451 | 11 | 16 | 216_225 | 367.0 | 548.0 | KDM1B |
Top |
Related Drugs to ADCY9-GLYR1 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to ADCY9-GLYR1 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |